Get the Stockscreener App
6.56
2.53%
-0.17
After Hours:
6.54
-0.02
-0.30%
Sensus Healthcare Inc stock is traded at $6.56, with a volume of 160.27K.
It is down -2.53% in the last 24 hours and down -15.68% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$6.73
Open:
$6.73
24h Volume:
160.27K
Relative Volume:
0.77
Market Cap:
$107.52M
Revenue:
$24.41M
Net Income/Loss:
$485.00K
P/E Ratio:
11.51
EPS:
0.57
Net Cash Flow:
$-2.37M
1W Performance:
+0.31%
1M Performance:
-15.68%
6M Performance:
+13.10%
1Y Performance:
+130.99%
1-Day Range:
$6.53
$6.89
1-Week Range:
$6.38
$6.93
52-Week Range:
$2.61
$9.3293
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
6.56 | 107.52M | 24.41M | 485.00K | -2.37M | 0.57 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
10 Under-the-Radar Stocks with Massive Upside for 2025 - Insider Monkey
Long Term Trading Analysis for (SRTS) - Stock Traders Daily
Jane Street Group LLC Sells 17,450 Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) - Defense World
Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Top 5 Small-cap Medical Device Stocks (Updated January 2025) - Investing News Network
Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update - MarketBeat
Sensus Healthcare, Inc. (NASDAQ:SRTS) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Simply Wall St
Sensus Healthcare, Inc. (NASDAQ:SRTS) Shares Bought by Geode Capital Management LLC - Defense World
(SRTS) Technical Data - Stock Traders Daily
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance
Global Inulinase Market to Surpass USD 1,613.8 Million by 2034, Driven by 4.9% CAGR and Expanding Applications in Food, Beverages, and Dietary Supplements | Future Market Insights, Inc. - GlobeNewswire Inc.
Those who invested in Sensus Healthcare (NASDAQ:SRTS) a year ago are up 204% - Yahoo Finance
How to Take Advantage of moves in (SRTS) - Stock Traders Daily
Sensus Healthcare (SRTS) Surges 7.9%: Is This an Indication of Further Gains? - MSN
Sensus Healthcare, Inc. (SRTS) Sees a More Significant Dip Than Broader Market: Some Facts to Know - MSN
Fidelity MSCI Energy Index ETF declares quarterly distribution of $0.1620 - MSN
Keloid Treatment Market Top PlayersNovartis AG, Sensus - openPR
(SRTS) Proactive Strategies - Stock Traders Daily
3 US Stocks That May Be Trading Below Their Estimated Value - Simply Wall St
Wall Street Bulls Look Optimistic About Sensus Healthcare (SRTS): Should You Buy? - MSN
Wall Street Analysts Believe Sensus Healthcare (SRTS) Could Rally 36.01%: Here's is How to Trade - MSN
Is Sensus Healthcare (SRTS) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in a Mobile Configuration - The Manila Times
Here's What Could Help Sensus Healthcare (SRTS) Maintain Its Recent Price Strength - Yahoo Finance
Sensus Healthcare Launches First Mobile Radiotherapy Service for Pets in Groundbreaking Veterinary Partnership - StockTitan
Sensus Healthcare (STU:5TX) Shares Outstanding (EOP) : 16.39 Mil (As of Sep. 2024) - GuruFocus.com
Sensus Healthcare (NASDAQ:SRTS) Knows How To Allocate Capital Effectively - Yahoo Finance
Sensus Healthcare (FRA:5TX) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
Sensus Healthcare, Inc. (SRTS) Recently Broke Out Above the 20-Day Moving Average - MSN
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025 - AccessWire
Wall Street Bulls Look Optimistic About Intuitive Surgical (ISRG): Should You Buy? - MSN
Sensus Healthcare, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Sensus Healthcare stock soars to 52-week high of $8.58 By Investing.com - Investing.com Canada
Sensus Healthcare stock soars to 52-week high of $8.58 - Investing.com India
HC Wainwright Predicts Higher Earnings for Sensus Healthcare - MarketBeat
HC Wainwright Boosts Sensus Healthcare (NASDAQ:SRTS) Price Target to $11.00 - Defense World
Sensus Healthcare (NASDAQ:SRTS) Revises Q2 2024 Financial Results in Recent 8-K Filing - Defense World
Wall Street Analysts See a 39.66% Upside in Sensus Healthcare (SRTS): Can the Stock Really Move This High? - MSN
What Makes Sensus Healthcare (SRTS) a Good Fit for 'Trend Investing' - MSN
FY2024 EPS Forecast for Sensus Healthcare Lifted by Analyst - MarketBeat
Results: Sensus Healthcare, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Simply Wall St
Maxim Group Forecasts Strong Price Appreciation for Sensus Healthcare (NASDAQ:SRTS) Stock - Defense World
Sensus Healthcare (NASDAQ:SRTS) Price Target Raised to $11.00 at HC Wainwright - MarketBeat
FY2024 EPS Estimate for Sensus Healthcare Boosted by Analyst - MarketBeat
Sensus Healthcare, Inc. (SRTS) Surpasses Q3 Earnings and Revenue Estimates - MSN
Equities Analysts Set Expectations for SRTS FY2024 Earnings - Defense World
REVISEDSensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter - The Manila Times
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):